FOXL2 posttranslational modifications mediated by GSK3β determine the growth of granulosa cell tumours

作者: Jae-Hong Kim , Yong-Hak Kim , Hong-Man Kim , Ho-Oak Park , Nam-Chul Ha

DOI: 10.1038/NCOMMS3936

关键词:

摘要: Approximately 97% of patients with ovarian granulosa cell tumours (GCTs) bear the C134W mutation in FOXL2; however, pathophysiological mechanism this is unknown. Here we report how affects GCT development. Sequential posttranslational modifications mutant occur where hyperphosphorylation at serine 33 (S33) by GSK3β induces MDM2-mediated ubiquitination and proteasomal degradation. In contrast, S33 wild-type FOXL2 underphosphorylated, leading to its SUMOylation stabilization. This prominent also observed bearing mutation. xenograft mice, phosphorylation status correlates oncogenicity FOXL2, inhibition efficiently represses growth. These findings reveal a previously unidentified regulatory that determines oncogenic attributes via differential

参考文章(37)
Jeehyeon Bae, Kangseok Lee, Jeong-Jae Ko, Sunyoung Lee, Tae Heon Kim, Jaesook Rho, Miae Won, Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation. International Journal of Gynecological Cancer. ,vol. 20, pp. 1341- ,(2010) , 10.1111/IGC.0B013E3181FF3E73
Fang-Ting Kuo, Ikuko K. Bentsi-Barnes, Gillian M. Barlow, Jeehyeon Bae, Margareta D. Pisarska, Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene. Cellular Signalling. ,vol. 21, pp. 1935- 1944 ,(2009) , 10.1016/J.CELLSIG.2009.09.001
Kasmintan A. Schrader, Bella Gorbatcheva, Janine Senz, Alireza Heravi-Moussavi, Nataliya Melnyk, Clara Salamanca, Sarah Maines-Bandiera, Susanna L. Cooke, Peter Leung, James D. Brenton, C. Blake Gilks, John Monahan, David G. Huntsman, The Specificity of the FOXL2 c.402C>G Somatic Mutation: A Survey of Solid Tumors PLoS ONE. ,vol. 4, pp. e7988- ,(2009) , 10.1371/JOURNAL.PONE.0007988
Rotem Gershon, Sarit Aviel-Ronen, Jacob Korach, Vered Daniel-Carmi, Camila Avivi, Dalia Bar-Ilan, Iris Barshack, Dror Meirow, Gilad Ben-Baruch, Yoram Cohen, FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors. Gynecologic Oncology. ,vol. 122, pp. 580- 584 ,(2011) , 10.1016/J.YGYNO.2011.05.008
Mira Park, Eunkyoung Shin, Miae Won, Jae-Hong Kim, Hayoung Go, Hyun-Lee Kim, Jeong-Jae Ko, Kangseok Lee, Jeehyeon Bae, FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells. Molecular Endocrinology. ,vol. 24, pp. 1024- 1036 ,(2010) , 10.1210/ME.2009-0375
Mira Park, Jiyou Han, Jeong-Jae Ko, Woo-Sik Lee, Tae Ki Yoon, Kangseok Lee, Jeehyeon Bae, Maternal exposure to fenarimol promotes reproductive performance in mouse offspring. Toxicology Letters. ,vol. 205, pp. 241- 249 ,(2011) , 10.1016/J.TOXLET.2011.05.1040
Nicholas I. Fleming, Kevin C. Knower, Kyren A. Lazarus, Peter J. Fuller, Evan R. Simpson, Colin D. Clyne, Aromatase Is a Direct Target of FOXL2: C134W in Granulosa Cell Tumors via a Single Highly Conserved Binding Site in the Ovarian Specific Promoter PLoS ONE. ,vol. 5, pp. e14389- 10 ,(2010) , 10.1371/JOURNAL.PONE.0014389
J-H Kim, S Yoon, M Park, H-O Park, J-J Ko, K Lee, J Bae, Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W). Oncogene. ,vol. 30, pp. 1653- 1663 ,(2011) , 10.1038/ONC.2010.541
Dirk Schmidt, Catherine E Ovitt, Katrin Anlag, Sandra Fehsenfeld, Lars Gredsted, Anna-Corina Treier, Mathias Treier, The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance Development. ,vol. 131, pp. 933- 942 ,(2004) , 10.1242/DEV.00969
Emanuela D'Angelo, Ana Mozos, Daiei Nakayama, Iñigo Espinosa, Lluis Catasus, Josefina Muñoz, Jaime Prat, Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary Modern Pathology. ,vol. 24, pp. 1360- 1367 ,(2011) , 10.1038/MODPATHOL.2011.95